Annals of Clinical and Translational Neurology · 2015 · 177 citations · 19 references
Life SciencesNeurologyNeuroscienceAutoimmunityImmunopathologyNeuroimmunologyAutoimmune Neurological DisordersDemyelinating DiseasesDemyelinating DisordersEncephalitisMultiple SclerosisNeurodegenerative DisordersMog Antibody DiseaseMog Antibody-associated DiseaseMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis PathologyMyelin AntigensMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseMyelin-associated Glycoprotein
We present histological, MRI, and clinical features of an adult patient with relapsing encephalomyelitis and antibodies against myelin oligodendrocyte glycoprotein (MOG). Furthermore, we report molecular details of the recognized epitope that is specific for human MOG. A brain biopsy revealed multiple sclerosis (MS)-type II pathology. Some features overlapped with both MS and neuromyelitis optica spectrum disorders (NMOSD), whereas others were distinct from both MS and NMOSD. Immunoadsorption and rituximab induced clinical stabilization. This case contributes a new, so far missing link in the emerging spectrum of MOG-antibody-associated encephalomyelitis.
19